ArticleClinical journal of gastroenterology2021

Pemafibrate, a novel selective PPARα modulator, attenuates tamoxifen-induced fatty liver disease.

Naoki Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.